Scarica l'app Stockscreener
57.31
2.32%
1.30
Dopo l'orario di chiusura:
57.31
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$56.01
Aprire:
$55.6
Volume 24 ore:
157.55K
Relative Volume:
0.45
Capitalizzazione di mercato:
$1.20B
Reddito:
$486.82M
Utile/perdita netta:
$18.78M
Rapporto P/E:
-119.40
EPS:
-0.48
Flusso di cassa netto:
$100.45M
1 W Prestazione:
-2.88%
1M Prestazione:
-0.90%
6M Prestazione:
-14.78%
1 anno Prestazione:
-12.41%
Intervallo 1D:
$55.55
$57.67
Intervallo di 1 settimana:
$55.55
$60.44
Portata 52W:
$48.20
$70.81
Ani Pharmaceuticals Inc Stock (ANIP) Company Profile
Nome
Ani Pharmaceuticals Inc
Settore
Telefono
(218) 634-3500
Indirizzo
210 MAIN STREET WEST, BAUDETTE, MN
Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-08-22 | Reiterato | H.C. Wainwright | Buy |
| 2023-03-01 | Iniziato | Guggenheim | Buy |
| 2022-09-07 | Iniziato | H.C. Wainwright | Buy |
| 2021-11-02 | Iniziato | Truist | Buy |
| 2020-05-07 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2019-09-12 | Iniziato | Guggenheim | Buy |
| 2019-05-10 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2017-10-16 | Reiterato | Canaccord Genuity | Buy |
| 2017-07-31 | Iniziato | Canaccord Genuity | Buy |
| 2017-02-22 | Downgrade | ROTH Capital | Buy → Neutral |
| 2016-06-23 | Iniziato | Raymond James | Strong Buy |
| 2016-05-24 | Downgrade | Standpoint Research | Buy → Hold |
| 2015-11-13 | Iniziato | Standpoint Research | Buy |
| 2015-09-28 | Aggiornamento | ROTH Capital | Neutral → Buy |
| 2015-08-05 | Reiterato | Oppenheimer | Outperform |
| 2015-08-04 | Reiterato | ROTH Capital | Neutral |
| 2015-07-31 | Reiterato | Oppenheimer | Outperform |
| 2015-07-15 | Reiterato | ROTH Capital | Neutral |
| 2015-06-23 | Reiterato | Oppenheimer | Outperform |
| 2015-05-18 | Reiterato | ROTH Capital | Neutral |
| 2015-05-06 | Reiterato | Oppenheimer | Outperform |
| 2015-04-10 | Downgrade | ROTH Capital | Buy → Neutral |
| 2015-02-26 | Reiterato | ROTH Capital | Buy |
| 2015-02-18 | Reiterato | Oppenheimer | Outperform |
Mostra tutto
Ani Pharmaceuticals Inc Borsa (ANIP) Ultime notizie
Gastroparesis Drugs Market to Grow by USD 1.42 Billion from 2024-2028, Driven by Rising Diabetes Rates and AI-Driven Market Trend InsightsTechnavio - The Malaysian Reserve
ANI Pharmaceuticals to Present at Guggenheim's Inaugural - GlobeNewswire
ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November - StockTitan
F M Investments LLC Buys Shares of 61,782 ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
ANI Pharmaceuticals Stock: Acting Like It Is Being Acquired (NASDAQ:ANIP) - Seeking Alpha
Earnings Preview: ANI Pharmaceuticals (ANIP) Q3 Earnings Expected to Decline - Yahoo Finance
ANI Pharmaceuticals (ANIP) to Release Quarterly Earnings on Friday - MarketBeat
ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET - GlobeNewswire
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Short Interest Down 9.7% in October - MarketBeat
Assenagon Asset Management S.A. Grows Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06% - GlobeNewswire
ANI Pharmaceuticals introduces generic Estradiol Gel By Investing.com - Investing.com South Africa
ANI Pharmaceuticals introduces generic Estradiol Gel - Investing.com
ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024 - The Manila Times
ANI Pharmaceuticals to Present New Data Highlighting - GlobeNewswire
ANI Pharmaceuticals price target raised to $62 from $60 at Truist - Yahoo Finance
Critical Insights From ANI Pharmaceuticals Analyst Ratings: What You Need To Know - Benzinga
ANI Pharmaceuticals (NASDAQ:ANIP) PT Raised to $62.00 at Truist Financial - MarketBeat
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? - Yahoo Finance
Avadel Obtains FDA Nod for Label Expansion Of Narcolepsy Drug Lumryz - Benzinga
Are Medical Stocks Lagging Alnylam Pharmaceuticals (ALNY) This Year? - Yahoo Finance
ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue? - Yahoo Finance
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) VP Sells $14,297.50 in Stock - MarketBeat
Ani Pharmaceuticals' sr. vp sells $14,297 in stock By Investing.com - Investing.com Canada
Ani Pharmaceuticals' sr. vp sells $14,297 in stock - Investing.com India
ANI Pharmaceuticals (NASDAQ:ANIP) Now Covered by Piper Sandler - Defense World
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
ANI Pharmaceuticals Shifts Focus From Generics To High-Margin Brand Assets, Analyst Sees Strong Potential - Yahoo Finance
ANI Pharmaceuticals And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity - Via News Agency
ANI Pharma stock earns bull at Piper Sandler (NASDAQ:ANIP) - Seeking Alpha
Piper Sandler Initiates Coverage on ANI Pharmaceuticals (NASDAQ:ANIP) - MarketBeat
Peeling Back The Layers: Exploring ANI Pharmaceuticals Through Analyst Insights - Benzinga
ANI Pharmaceuticals: A Rare GARP Stock In An Overbought Market - Seeking Alpha
While shareholders of ANI Pharmaceuticals (NASDAQ:ANIP) are in the black over 3 years, those who bought a week ago aren't so fortunate - Simply Wall St
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Shares Acquired by Millennium Management LLC - MarketBeat
Algert Global LLC Decreases Stock Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance - GlobeNewswire
Dimensional Fund Advisors LP Boosts Stock Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Short Interest Down 8.3% in September - MarketBeat
Maverick Capital Ltd. Has $1.18 Million Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now? - Yahoo Finance
Drugs for Arrhythmia Market Demand and Business Outlook | Sanofi, Boehringer Ingelheim Pharmaceuticals, Inc, ANI Pharmaceuticals – Cauverynews - Cauverynews
ANI Pharmaceuticals launches generic Ketoconazole Shampoo - Investing.com India
ANI Pharmaceuticals launches generic Ketoconazole Shampoo By Investing.com - Investing.com Canada
ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2% - The Manila Times
American Century Companies Inc. Purchases 49,717 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
ANI Pharmaceuticals (NASDAQ:ANIP) Stock Quotes, Forecast and News Summary - Benzinga
Renaissance Technologies LLC Raises Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
It makes sense and dollars to buy ANI Pharmaceuticals Inc (ANIP) stock - SETE News
Ani Pharmaceuticals Inc Azioni (ANIP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.88%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):